Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LEVP2006-1 CHANGE 2 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Safety/Efficacy Repeat Exposure Study of C1INH-nf (Human) in the Treatment of Acute HAE Attacks

NCT00438815 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00438815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00438815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LEVP2006-1 CHANGE 2 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Safety/Efficacy Repeat Exposure Study of C1INH-nf (Human) in the Treatment of Acute HAE Attacks
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
September 21, 2006
Completion date
March 31, 2009
Enrollment
113 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema